Literature DB >> 12699665

New synthetic biodegradable polymers as BMP carriers for bone tissue engineering.

Naoto Saito1, Kunio Takaoka.   

Abstract

Bone morphogenetic proteins (BMPs) are biologically active molecules capable of inducing new bone formation and are expected to be used clinically in combination with biomaterials such as bone-graft substitutes to promote bone repair. The carrier materials for BMPs have to not only secure the BMPs in the local area and diffuse them afterwards, but also to provide scaffolding for the newly formed bone. Since synthetic, biodegradable polymers with optimal properties are considered most desirable, we synthesized polylactic acid and its derivatives. Some of these were found to consistently induce ectopic bone formation when combined with BMP and implanted into the muscles of experimental animals. It was also found that the three-dimensional configuration of BMP-induced bone mass could be controlled. This means that our attempt to construct synthetic biomaterials which can induce controllable bone formation was successful.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12699665     DOI: 10.1016/s0142-9612(03)00040-1

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  26 in total

1.  Bioglass as a carrier for reindeer bone protein extract in the healing of rat femur defect.

Authors:  Hanna Tölli; Sauli Kujala; Katri Levonen; Timo Jämsä; Pekka Jalovaara
Journal:  J Mater Sci Mater Med       Date:  2010-02-17       Impact factor: 3.896

Review 2.  Biomimetic coatings for bone tissue engineering of critical-sized defects.

Authors:  Yuelian Liu; Gang Wu; Klaas de Groot
Journal:  J R Soc Interface       Date:  2010-05-19       Impact factor: 4.118

3.  Pre-incubation of chemically crosslinked hyaluronan-based hydrogels, loaded with BMP-2 and hydroxyapatite, and its effect on ectopic bone formation.

Authors:  Sonya Stenfelt; Gry Hulsart-Billström; Lars Gedda; Kristoffer Bergman; Jöns Hilborn; Sune Larsson; Tim Bowden
Journal:  J Mater Sci Mater Med       Date:  2014-01-30       Impact factor: 3.896

4.  Efficacy of interspinous process lumbar fusion with recombinant human bone morphogenetic protein-2 delivered with a synthetic polymer and β-tricalcium phosphate in a rabbit model.

Authors:  Tomiya Matsumoto; Hiromitsu Toyoda; Sho Dohzono; Hiroyuki Yasuda; Shigeyuki Wakitani; Hiroaki Nakamura; Kunio Takaoka
Journal:  Eur Spine J       Date:  2011-12-28       Impact factor: 3.134

Review 5.  Studies of bone morphogenetic protein-based surgical repair.

Authors:  Kevin W-H Lo; Bret D Ulery; Keshia M Ashe; Cato T Laurencin
Journal:  Adv Drug Deliv Rev       Date:  2012-04-02       Impact factor: 15.470

6.  Experimental research on ectopic osteogenesis of BMP2-derived peptide P24 combined with PLGA copolymers.

Authors:  Zhixia Duan; Qixin Zheng; Xiaodong Guo; Quan Yuan; Shunguang Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-04

7.  Morphological differences in BMP-2-induced ectopic bone between solid and crushed hyaluronan hydrogel templates.

Authors:  Gry Hulsart-Billström; Sonya Piskounova; Lars Gedda; Britt-Marie Andersson; Kristoffer Bergman; Jöns Hilborn; Sune Larsson; Tim Bowden
Journal:  J Mater Sci Mater Med       Date:  2013-02-08       Impact factor: 3.896

8.  Elastomeric enriched biodegradable polyurethane sponges for critical bone defects: a successful case study reducing donor site morbidity.

Authors:  Catarina Lavrador; Ramiro Mascarenhas; Paulo Coelho; Cláudia Brites; Alfredo Pereira; Sylwester Gogolewski
Journal:  J Mater Sci Mater Med       Date:  2016-01-22       Impact factor: 3.896

9.  Synthetic alginate is a carrier of OP-1 for bone induction.

Authors:  Katsuhiko Nanno; Kenjiro Sugiyasu; Takashi Daimon; Hideki Yoshikawa; Akira Myoui
Journal:  Clin Orthop Relat Res       Date:  2009-05-28       Impact factor: 4.176

10.  Engineering endochondral bone: in vitro studies.

Authors:  Serafim M Oliveira; Isabel F Amaral; Mário A Barbosa; Cristina C Teixeira
Journal:  Tissue Eng Part A       Date:  2009-03       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.